Lument Finance Trust Shakes Up 2025 With a $664 Million CRE CLO Closing

Lument finance trust logo

If your morning coffee needs a little excitement, how about a $663.8 million deal to go with it? Lument Finance Trust (NYSE: LFT) has officially closed its latest commercial real estate collateralized loan obligation, known as LMNT 2025-FL3—a move sparking conversation across the CRE finance world.

This massive, managed CRE CLO features a strategic reinvestment period, a diverse national footprint, and deal terms signaling a market pushing back toward growth. For real estate and finance professionals—especially those expanding into CRE debt structures—this is the kind of headline worth a deeper look.

A Closer Look at the Deal

LFT successfully placed nearly $585 million in investment‑grade securities with institutional investors. Even more impressive, the financing carries a non-mark-to-market, non-recourse structure—offering long-term stability rarely guaranteed in today’s market.

Key Deal Stats

• Total CLO size: $663.8 million
• Advance rate: 88.1%
• Weighted average interest rate: Term SOFR + 1.91%
• Reinvestment period: 30 months
• Collateral spread: ~321 bps over 1‑month SOFR
• Collateral: 32 loans across 49 multifamily & commercial properties

Some collateral was already held by LFT prior to closing, while additional assets were acquired from Lument Investment Management, its external manager. With properties spanning the U.S., the pool delivers meaningful diversification—an essential pillar in transitional CRE debt strategies.

Who Helped Make It Happen?

J.P. Morgan Securities LLC served as the sole structuring agent, lead manager, and bookrunner—an elite trifecta. Citizens JMP Securities, LLC supported the transaction as a co‑manager.

Why Real Estate Professionals Should Pay Attention

CRE finance is evolving rapidly, driven by floating‑rate structures, transitional assets, and shifting capital markets. Landmark deals like this don’t just shape markets—they influence how properties are financed, repositioned, and ultimately valued nationwide.

For professionals pursuing careers in real estate investing, mortgage finance, or capital markets, understanding transactions of this scale builds a sharper competitive edge. And if you’re leveling up your career through licensing or specialty certifications, staying informed is half the battle.

That’s where Cameron Academy comes in—offering flexible, accessible licensing courses in Florida real estate, mortgage, insurance, finance, and dozens of other fields across all 50 states. When major market moves take place, the pros trained here understand them first.

About Lument Finance Trust

LFT is a Maryland corporation specializing in commercial real estate debt investments, with emphasis on transitional floating‑rate loans for the middle‑market multifamily sector. The company is externally managed by Lument Investment Management, LLC.

Whether you’re a seasoned investor, an analyst sharpening your expertise, or a professional earning new credentials, keeping tabs on CRE finance movements like this ensures you stay ahead of the market—and ahead in your career.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Is Florida’s Booming Real Estate Market Becoming Unaffordable?

Florida is facing a real estate crisis marked by skyrocketing insurance premiums, stringent FEMA rules, and a surge in hedge fund property acquisitions.

By |November 14, 2024|Categories: Article, Finance/Economy, Real Estate|Tags: , |0 Comments

Revolutionizing Cancer Therapy: The Promise of Patient-Derived Organoids

Patient-derived organoids offer an unprecedented opportunity to replicate the complex structure and genetic makeup of cancers, providing a more accurate model for clinical drug screening and pharmacognostic assessment.

The AI Revolution in Dermatology: A Systematic Review

In a groundbreaking study published in Nature, researchers have delved into the burgeoning field of artificial intelligence (AI) in dermatology, specifically examining its role in diagnosing skin cancer. The study, titled "A Systematic Review and Meta-Analysis of Artificial Intelligence Versus Clinicians for Skin Cancer Diagnosis," offers a comprehensive look at how AI stacks up against human clinicians in this critical area of healthcare.

By |November 14, 2024|Categories: AI in Healthcare, Article, Dermatology|Tags: , |0 Comments

The Fast Lane to Fully Autonomous Vehicles: Industry Innovations and Future Prospects

The automotive world is abuzz with announcements from major players like Tesla, Rimac, Renault, and Nissan, each unveiling plans to introduce autonomous vehicles in the near future. Tesla's much-anticipated "CyberCab" is set for an October 2024 debut, while Rimac and Renault are gearing up for releases in 2026.

Futureproofing for Insurers: The Role of AI and Hyper-Personalization

In a rapidly evolving industry, insurance companies are turning to artificial intelligence (AI) and hyper-personalization to stay ahead of the curve.

Revolutionizing Healthcare: The Power and Potential of AI

AI technology offers a multitude of benefits, from enhancing patient outcomes to reducing healthcare costs and improving population health. Its application ranges from preventive screenings to complex diagnostic procedures, marking a new era in medical care.

By |November 13, 2024|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments